BRAF and metastatic melanoma: The higher expression of DNMT1 and EZH2 is concordant with previous observations in BRAF-mutated cells, such as it is the case for WM266-4, described to participate in the hypermethylated phenotype of metastatic melanoma cells ([36] and personal observations).